Sd-021, derivatives of decursin, inhibits tumorigenesis in NSCLC by inhibiting the EGFR/STAT3 signaling pathway

Abstract Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a significant challenge in oncology despite advances in targeted and immune-based therapies. NSCLC accounts for approximately 85% of all lung cancer cases, with five-year survival rates ranging from 4 to 17%, depending on...

詳細記述

書誌詳細

主要な著者:	Hyun-Ha Hwang, Jeong-Hui Je, Hyeong-Chan Lee, Ji-Sung Yoo, Taehyoun Kim, Jung Hwan Choi, Jin Won Hong, Hae-In Lim, Ga Yoon Kim, Yun-Beom Sim, Kwang-Jin Cho, Eun-wook Choi, Chunhoo Cheon, Jae Yeol Lee, Seong-Gyu Ko
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2025-07-01
シリーズ:	Scientific Reports
主題:	Sd-021 Decursin derivatives Non-small cell lung cancer (NSCLC) EGFR/STAT3 signaling pathway
オンライン･アクセス:	https://doi.org/10.1038/s41598-025-05715-5
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!